Clinical Trial Update: Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effects of Darapladib (SB-480848) on electrical conduction in patients with atherosclerosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED